Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

Funds / MED 1

MED 1

Early deploymentbuyout or unlabelledADV: Private Equity FundArchimedFrance
Amounts, each with its basis
Vintage
2023basis: first reported on Form ADV
Target
unknownnot announced
First close
unknownnever inferred from a Form D
Final close
unknownonly from an announcement or an LP disclosure
Announced size
unknown
Form D offering
unknownwhat may be sold, not what was raised
Form D sold
unknownno Form D on record
First sale
unknown
Reported gross assets
$161MForm ADV, as of Mar 19, 2024; not fund size, not dry powder
Peak reported gross assets
$161Mhighest year on the reporting tape
Owners (ADV)
39
Reported on ADV
Mar 30, 2023 to Mar 19, 2024
Structure
standalone
Fund of funds (ADV)
no
Lifecycle
Early deployment
rule: first reported within 2 years and gross assets risingmodel: lc-pe-1gav path: 2023,156189505,2024,161298507peak gav: $161Mas of year: $2,024latest gav: $161Mreported years: 2last step change: 0.033age years at as of: 1drawdown from peak: 0first reported year: $2,023
Reported gross assets by year
2 annual rows
YearFiledTypeGross assets OwnersMin. investmentNon-US ownedSource
2023Mar 30, 2023Private Equity Fund$156M
56$5.3M100%adviserinfo.sec.gov
2024Mar 19, 2024Private Equity Fund$161M
39$5.5M100%adviserinfo.sec.gov
Placement agents and principals
1 placement agents, 0 principals
  • Triago placement agent since Jan 1, 2023 Fact
Limited partners
0 disclosed
No LP commitment to this fund collected yet. An LP appears only when a public disclosure names this fund.
Investments attributed to this fund
0
No investment attributed to this fund. A firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Events
1 most recent
  1. Mar 30, 2023
    MED 1 first reported on Form ADV by Archimed (Private Equity Fund), GAV $156,189,505